Buzz Stocks: Alcoa Inc, Fastenal Company, and SAGE Therapeutics Inc

Today's stocks to watch in the news include Alcoa Inc (NYSE:AA), Fastenal Company (NASDAQ:FAST), and SAGE Therapeutics Inc (NASDAQ:SAGE)

by Celeste Taylor

Published on Jul 12, 2016 at 10:21 AM
Updated on Jul 12, 2016 at 10:23 AM

U.S. stocks are trekking deeper into uncharted territory, following a strong start to second-quarter earnings season. Among equities in focus today are aluminum stock Alcoa Inc (NYSE:AA), construction equipment supplier Fastenal Company (NASDAQ:FAST), and biotech SAGE Therapeutics Inc (NASDAQ:SAGE).

  • AA is up 3% at $10.44, after the company reported better-than-anticipated second-quarter earnings. The shares of Alcoa Inc also received $1 price-target hikes from J.P. Morgan Securities and Stifel, to $10 and $13, respectively. Today's surge has Alcoa breaking out above $10.20, a level that has largely contained the shares since late last year. What's more, AA stock is now up 6% year-to-date. On the sentiment front, short interest fell 1.4% in the most recent reporting period, but these bearish bets still make up 10.1% of AA's float, which would take about 7.4 days to cover, at the equity's average daily volume.
  • FAST is down 3.5% at $43.78, after the company reported second-quarter earnings that missed the mark. Nevertheless, the shares of Fastenal Company are still up 7.3% year-to-date, and appear to have found a foothold in the $43.50 region -- a level that supported FAST in mid-June. Short sellers, meanwhile, have been jumping ship, with short interest down 3.4% in the last two reporting periods. However, 11.6% of FAST's float is still sold short -- or 14.6 times FAST's average daily trading volume -- leaving ample sideline cash to help boost the shares, should they resume their longer-term uptrend.
  • SAGE is up 35.8% at $45.71, after its postpartum depression drug, SAGE-547, met its mid-stage study goal. Despite this meteoric rise, SAGE has struggled over the long term, down 22% year-to-date -- and today's surge is running out of steam near the 320-day moving average, a trendline not conquered on a daily closing basis since Jan. 5. In the options pits, SAGE Therapeutic Inc's Schaeffer's put/call open interest ratio (SOIR) of 0.57 sits at the very bottom of its annual range. In other words, short-term option players are the most call-biased they've been in the past 12 months.
Sign up now for Schaeffer's Opening View newsletter to get a head start on all the major pre-market news!

A Schaeffer's exclusive!

The Expert's Guide

Access your FREE trading earning announcements before it's too late!



NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories

With This Lithium Stock, It Will Be Better to Be Too Early Than Too Late
Click to continue to advertiser's site.
American Airlines Drops on Jobs Update
American Airlines said it will reduce management and support staff by 30%
June Kicks Off With Slew of Economic Data
June begins with another round of retail earnings
With This Lithium Stock, It Will Be Better to Be Too Early Than Too Late
Click to continue to advertiser's site.